Compounds > chlorzoxazone

chlorzoxazone and isoproterenol

chlorzoxazone has been researched along with isoproterenol in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bridges, RJ; Devor, DC; Gerlach, AC; Gondor, M; Pilewski, JM; Singh, AK1
Ishikawa, T; Ito, Y; Kondo, M; Kume, H; Nakayama, S; Sato, S; Shimokata, K; Son, M1

Reviews

1 review(s) available for chlorzoxazone and isoproterenol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

4 other study(ies) available for chlorzoxazone and isoproterenol

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Stimulation of Cl(-) secretion by chlorzoxazone.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 292, Issue:2

    Topics: Amiloride; Anions; Bronchi; Bumetanide; Cell Membrane; Cells, Cultured; Charybdotoxin; Chlorine; Chlorzoxazone; Colforsin; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Interactions; Epithelium; Glyburide; Humans; Isoproterenol; Nasal Mucosa; Nystatin; Potassium Channel Blockers; Rubidium; Zoxazolamine

2000
ATP release triggered by activation of the Ca2+-activated K+ channel in human airway Calu-3 cells.
    American journal of respiratory cell and molecular biology, 2004, Volume: 30, Issue:3

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Benzimidazoles; Bumetanide; Calcium; Cell Size; Charybdotoxin; Chlorzoxazone; Colforsin; Cystic Fibrosis Transmembrane Conductance Regulator; Cytosol; Epithelial Cells; Glyburide; Humans; Ionomycin; Isoproterenol; Luciferases; Lung; Potassium Channels, Calcium-Activated; Potassium Chloride; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y1

2004